Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jan 27, 2017 (10 years ago)

MakeSense PHARMA ANTIFUNGAL CREAM Clotrimazole 1%

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

MakeSense PHARMA ANTIFUNGAL CREAM Clotrimazole 1%, 1.25 oz. (35 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-203-35

Affected NDC 69020-0203-35

Compare with the code on your package — it is the most precise check available.

Drug: Clotrimazole

Recalling firm
Cherry Hill Sales Co.
NDC code
69020-203-35
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0487-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Clotrimazole recalls

See all
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0638-2026
Class II · Moderate risk

Cura Hongos

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0634-2026
Class II · Moderate risk

Lucky Super Soft

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0629-2026

Other recalls by Cherry Hill Sales Co.

All 2017 recalls
Class II · Moderate risk

MakeSense PHARMA

CGMP Deviations

Terminated cGMP deviation Cherry Hill Sales Co. NDC 69020-205-28 D-0483-2017